Not a typical AIM share as not a large amount of shares in circulation, this makes it difficult to buy and sell at times so making it hard for the traders to manipulate Any news could send this much higher. Company seems to have a good recovery plan and so worth a punt but don't invest your life savings just in case |
Quite the opposite actually- world class management team . Only top drawer management teams can secure 6 million pound grants. No go shuffle off to vanquis |
Management are scumbag ... will bankrupt all investors |
You are very welcome to your view Sikh and it's always good to have opposing views on boards. But when the share price was falling no one really questioned that either and now that it's rising you think it too good be to true. Why?There will always be pumpers and dumpers but i am in for the long haul and I am happy and confident in my decision. You are more than capable of making your own mind up so I won't slate you whatever you decide |
Take a lie down over the weekend bud. You've had a stressful day trying to grasp fusion . |
ImDandy
"Latest house broker conclusion written a few weeks ago."
That's my point, few weeks ago. In fact a month since the Grant rns. The shares have already more than doubled since start of Dec.
There's nothing since to backup why they have risen sharply this week. |
Take a couple of nurofen mate. You clearly know nothing about this company. That's obvious |
Take a break mste |
Look at the trades, grouped together and traded within a few secs... That pushes the share price higher. It's not genuine investors but traders. Exactly same happens on others which were pumped/dumped.
I bought a few today for the same reason as Byot and Trmr(now nexn).. It is being pumped/dumped. Again, I'll try and sell before the p&d gang do!!
Byot - now delisted.
and Trmr (now nexn).
According to some posters, there's supposedly a TU due. Let's see what the company has to say.
Best to trade |
Read this over the weekend. Latest house broker conclusion written a few weeks ago. Fusion's market capitalisation is £4.3m, suggesting an EV of £3.9m. We consider this to represent a geared situation tied to the success of Fusion's recovery plan, given almost no value is being ascribed to its class leading antibody discovery technologies. Given there is evidence of a turnaround in its fortunes and that sales and margins are on an upward trajectory, our investment thesis is that investors will start to recognise the value inherent in Fusion's class leading antibody discovery technology. To highlight this, we would draw attention to the valuation of Absci (Nasdaq: ABSI), an albeit much-larger US/Canadian-based firm that has an AI-led approach to antibody drug design. This company has a market capitalisation of $447m and cash of $145m, hence an EV of $302m. |
I must admit that it's always amusing that a few envious clowns never fail to try and embarrass themselves. Usually quite successfully lol. |
Yeah it's a pump and dump. Happy??? Now do one. |
Thiopa, thanks for the bull case.
If big pharmas were going to buy, why wouldn't they already done so, given the Grant rns was a month ago and interims before that?
There's no recent news showing why they rose this week. Just trader talk by some, whilst HVO thread, which had similar trader talk at beginning of last year, has gone silent. |
Lowest ASk on show is now 8.5p, with that being paid, within the very barest of smidgeons below.
f. |
Wait until we are through 20p - will be some fun and games then |
Think they let a few mates in a bit cheaper ijd. |
What was that fake shake about? |
And up we go, thanks MM's as you done me a lovely favour dropping the SP |
Well I have had a few top ups on this little tree shake,MM's tried Thier best but drop done now and I expect this to be in positive territory by close,too risky to be out of this one as news could drop anytime from next Monday when the company will be back working after the Christmas break. |
Agree momentum starts next week. Adrian said the quarterly updates last year were to show evidence their recovery plan and their words were true. He did also say not the norm for them to do quarterly but that’s not to say if there are material contracts or r&d updates we won’t see something soon! They’ve a lot of irons in the fire and the grant for FMI may well change the landscape and their revenue cost mix for the significantly better |
Of course they will be happy to fill it lower, it's Friday of a broken week, I think the real momentum starts next week. Trading update after Q1 was 4 days in to the new period, the H1 was 8 days in to the new period (at AGM), if they are going to continue to give quarterly updates (and they haven't said they would), then I am looking at something next week? |
Got to agree trout |
MMs still bidding for over £25k's worth at 8p, still think someone is accumulating a big order. |